Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Mark S. Schroeder who wrote (1600)	3/26/1998 2:01:00 PM
From: the Chief	Respond to of 8117

Hi Mark "twas my prediction", it is the least we can expect! Orders is the most we can expect!! the Chief

To: Mark S. Schroeder who wrote (1600)	3/27/1998 3:57:00 PM
From: ufo	Read Replies (1) \| Respond to of 8117

Yep, I just bought 400 shares at $ CDN 4.90 partly on the strength of what I read here. I hope I haven't pulled another AFFX and bought at the wrong spot in a cycle. (I bought that at $45, but I'm hopeful that it will become the biotech equivalent of MSFT at some time in the next few years). All the bull opinions on PYNG that I've come across here and elsewhere are more convincing (and more numerous) than the bears and the financials on www.sedar.com for this company (once you get past their penchant for posting most stuff in wp6.0 format) look reasonable for a company at this stage in its development. I also like the fact that PYNG is working on a heart valve and have a large share in another company, so their future isn't totally dependent on this FASST thing-- though of course, it would take a large hit if there was something seriously wrong with the technology. I would be very shocked if any show stoppers came up at this stage, since they've already had successful training sessions on the FASST technology with medical folks here in Vancouver at two well known local hospitals.